Furthermore, Wu et al. have reported that isoliquiritigenin ameliorated the inflammatory process in various psoriasis models, including VEGF transgenic mouse, the imiquimod-induced psoriasis-like mouse, and the human keratinocytes HaCaT and NHEK cell [57]. The gene discussed is VEGFA; the disease is psoriasis.